Company intelligence / Profile preview

Mendelian

London, England, United Kingdommendelian.co ↗

Ownership: Private
Development stage: Commercial

Overview

Mendelian has developed and commercialized a digital health platform, MendelScan, which encodes case-finding criteria for rare and hard-to-diagnose diseases. The solution is used within primary care to identify undiagnosed patients earlier and is deployed within the UK National Health Service (NHS)[3][5].

Therapeutic areas: Rare Diseases
Modalities: Non-pharmacological therapy (digital health platform)
Industry: Digital Health Medical Devices

Partnerships

NHS (UK National Health Service)[3]

Beyond the preview

Go deeper on Mendelian.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mendelian.

Explore the full profile